Rose DiMartino's most recent trade in abrdn Japan Equity Fund Inc was a trade of 636 Common Stock done at an average price of $8.0 . Disclosure was reported to the exchange on Sept. 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
abrdn Japan Equity Fund Inc | Rose DiMartino | Director | Sale or transfer of securities back to the company at price $ 8.04 per share. | 03 Sep 2025 | 636 | 364 (0%) | 0% | 8.0 | 5,113 | Common Stock |
abrdn Japan Equity Fund Inc | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 6.19 per share. | 02 Oct 2024 | 1,000 | 1,000 (0%) | 0% | 6.2 | 6,190 | Common Stock |
Tekla Healthcare Investors | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 18.88 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 18.9 | 18,880 | Common Stock |
Tekla Life Sciences Investors | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 15.53 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 15.5 | 15,530 | Common Stock |
Tekla Healthcare Opportunities | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 21.30 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 21.3 | 21,300 | Common Stock |
Tekla World Healthcare Fund | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 13.31 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 13.3 | 13,310 | Common Stock |